Please login to the form below
Trobalt
This page shows the latest Trobalt news and features for those working in and with pharma, biotech and healthcare.
GSK/ Valeant's Trobalt set for EU restrictions
GSK/ Valeant's Trobalt set for EU restrictions. Eye concerns prompt CHMP to recommend last-line use for the epilepsy drug. ... European regulatory advisors have recommended GlaxoSmithKline and Valeant's epilepsy drug Trobalt be restricted after safety
Latest news
-
Eisai launches epilepsy drug Fycompa in UK
Comparing uptake, however, both Zebinix and Vimpat had slow starts before achieving fast acceleration, whereas uptake for Trobalt was “ very, very slow” according to Hendler.
-
Therapy focus: Epilepsy
In May 2011, GlaxoSmithKline launched its new epilepsy medicine Trobalt in the UK.
-
FDA approves GSK/Valeant anti-seizure drug
In the EU, ezogabine is known as retigabine (Trobalt). The drug received marketing authorisation in the EU in March 2011.
-
GSK launches first-in-class epilepsy drug
GSK launches first-in-class epilepsy drug. GSK introduces Trobalt for the adjunct treatment of adults with partial-onset seizures. ... GlaxoSmithKline (GSK) has launched Trobalt (retigabine), the first in a new class of anti-epileptic drug (AED), for the
-
GSK sales fall for first quarter of 2011
Recent approvals for GSK include lupus drug Benlysta (belimumab), Horizant (gabapentin enacarbil) for Restless Legs Syndrome and epilepsy treatment Trobalt (retigabine).
More from news
Approximately 1 fully matching, plus 5 partially matching documents found.
Latest Intelligence
-
Country report: The healthcare market in Germany
Committee and the same 'no proof' decision was reached regarding GlaxoSmithKline's Trobalt (retigabine) for epilepsy.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Senior Medical Writer (Remote Working)
-
Competitive Salary Offered
-
Senior Medical Writer
-
Competitive Salary
- Digital Manager, London – Healthcare Brandcomms, Medcomms, PR
-
Excellent package
- Account Manager, Healthcare Public Affairs
-
£32, 000 – £40, 000 benefits
-
Senior Medical Writer
-
Great salary and benefits
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Director, Market Access / HEOR - North-West
-
Negotiable
- Scientific Director / Editorial Team Leader
-
Great salary and benefits
-
Account Manager / Account Director
-
Competative
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Account Director
-
Excellent benefits
- Senior Account Executive, London, Medical Communications
-
Excellent package
- Senior Systematic Review Analyst - Oxford
-
Negotiable
Subscribe to our email news alerts
- Worldwide Clear Aligner Market to grow at a CAGR of 16.15% By 2023
- Worldwide Prenatal and New-born Genetic Testing Market Set to Register 11.9% CAGR During 2018-2024
- Medical Biomimetics Market soaring at 5.5% CAGR to Hit USD 34.4 Billion By 2024
- Medical Marijuana Market to Soar at 36% CAGR to 2024
- Worldwide Medical Ultrasound Imaging Equipment Market to Witness Robust Expansion Throughout the Forecast Period 2018 – 2023
- Worldwide Home Infusion Therapy Market Soaring at 9% CAGR to Hit USD 28 Billion by 2024
PMHub
Weber Shandwick
At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...
Latest intelligence
- OUTiCO win Best in UK Pharmaceutical Outsourcing award
- The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
- Artificial Intelligence in Healthcare
- Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
- World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
- Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...
Quick links
Infographics
